1795美時｜台灣從事困難學名藥與癌症學名藥之製造及銷售廠商，備受世界期待的台灣本土學名藥廠。受到Alvogen Group私募青睞前景可期｜ 投資Ｇ觀點
2022/9/2
投資G觀點
Frequently requested episodes will be transcribed first
Shownotes Transcript
No transcript made for this episode yet, you may request it for free.